Back to search

Article

Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis

2024-11-15

Abstract excerpt

<h4>Introduction</h4> Focal segmental glomerulosclerosis (FSGS) is a significant cause of chronic kidney disease and triggered by podocyte damage which can result in cytoskeletal alterations leading to foot process effacement. Vincristine is a chemoprotective drug which alters cytoskeletal microtubules and has been used clinically to reverse FSGS. However, the mechanisms underlying the beneficial effect of vincri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
829c74b2-6ea1-5d18-acad-5cfd7d4961ea
DOI
10.1101/2024.11.13.623397
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosisDOI 10.1101/2024.11.13.623397
Select a neighboring publication to make it the new centre.